Why the study?
Does bedside echocardiography of TAPSE/PASP predict survival in patients with COVID-19 ARDS?
Does bedside echocardiography of TAPSE/PASP predict survival in patients with COVID-19 ARDS?
Bedside echocardiographic assessment of right ventricular-arterial uncoupling (TAPSE/PASP) provides additional prognostic value for survival beyond standard oxygenation metrics in COVID-19 ARDS.
May refine prognostication in COVID-19 ARDS beyond PaO2/FIO2; hypothesis-generating and requires prospective validation.
COVID-19 ARDS is associated with clinically relevant uncoupling of right ventricular function from the pulmonary circulation; bedside echocardiography of TAPSE/PASP adds to the prognostic relevance of PaO₂/FIO₂ in ARDS on COVID-19.
No takes yet. Share an insight, caveat, or question.
D’Alto et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: